Healthcare Industry News: Stereotactic
News Release - February 27, 2006
BrainLAB Wins Patent Infringement Case -- Jury Verdict OverturnedWESTCHESTER, Ill., Feb. 27 (HSMN NewsFeed) -- On Friday, the US District Court in Denver, Colorado, dismissed the patent infringement lawsuit filed by Medtronic against BrainLAB in 1998. The Court ruled that, as a matter of law, BrainLAB's image-guided surgery/radiotherapy products do not infringe any of the patents in suit, determining that the evidence does not support a finding of infringement.
In September 2005, a Denver jury had reached a verdict finding that BrainLAB infringed four patents held or licensed by Medtronic, and determined that a reasonable royalty on BrainLAB product sales in the United States amounted to $51 million. The Court's ruling set aside that jury verdict and precludes the injunction Medtronic had been seeking.
"We are pleased to see that the Court has confirmed the uniqueness of our image-guided technology and that our technology does not infringe Medtronic's patents," said Stefan Vilsmeier, BrainLAB founder and CEO. "We look forward to continued success in our surgical navigation business and to supplying our partners with our advanced technology."
BrainLAB (www.brainlab.com), a privately held company headquartered in Munich, Germany, was founded in 1989 and is specialized in the development, manufacture, and marketing of medical technology for neurosurgery, radiosurgery / radiotherapy, orthopedics, trauma, and ENT. Among the products developed by BrainLAB are software and hardware components for image-guided surgery and radiotherapy as well as integrated systems for Stereotactic radiosurgery. With over 2,000 systems installed in over 65 countries, BrainLAB is among the market leaders in image-guided medical technology. BrainLAB today employs more than 740 people worldwide and has 15 offices across Europe, Asia, North and South America.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.